HR 3772 · 116th Congress · Health

Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019

Introduced 2019-07-16· Sponsored by Rep. Peters, Scott H. [D-CA-52]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2019-07-17)

Plain Language Summary

[AI summary unavailable — showing source text] Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2020 and as adjusted based on a specified fee schedule factor in each year thereafter.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

14 Democrats6 Republicans
Rep. Rush, Bobby L. [D-IL-1]IL
Rep. Holding, George [R-NC-2]NC
Rep. Lieu, Ted [D-CA-33]CA
Rep. McGovern, James P. [D-MA-2]MA
Rep. Burchett, Tim [R-TN-2]TN
Rep. Loebsack, David [D-IA-2]IA
Rep. Soto, Darren [D-FL-9]FL
Rep. Slotkin, Elissa [D-MI-8]MI
Rep. Moulton, Seth [D-MA-6]MA
Rep. Rouda, Harley [D-CA-48]CA
Rep. Phillips, Dean [D-MN-3]MN
Rep. Krishnamoorthi, Raja [D-IL-8]IL
Rep. Watson Coleman, Bonnie [D-NJ-12]NJ
Rep. Brooks, Susan W. [R-IN-5]IN
Rep. Lowenthal, Alan S. [D-CA-47]CA
Rep. Rutherford, John H. [R-FL-4]FL
Rep. Sewell, Terri A. [D-AL-7]AL
Rep. Murphy, Gregory [R-NC-3]NC
Rep. Kuster, Ann M. [D-NH-2]NH
Rep. Walorski, Jackie [R-IN-2]IN